Ion Channel Signaling in Cancer

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".

Deadline for manuscript submissions: 30 April 2024 | Viewed by 2278

Special Issue Editors


E-Mail Website
Guest Editor
Department of Health Sciences, Clinical Pharmacology Unit, University of Florence, 50139 Florence, Italy
Interests: neuroscience; pharmacology; ion channel; pain
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, 50139 Florence, Italy
Interests: neuroscience; pharmacology; ion channel; pain

E-Mail Website
Guest Editor
Department of Health Sciences, Clinical Pharmacology Unit, University of Florence, 50139 Florence, Italy
Interests: neuroscience; pharmacology; ion channel; pain
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Cancer refers to many diseases characterized by the development of abnormal and uncontrollably cells grow with the ability to spread, infiltrate, and destroy other regions and organs in normal body tissue. This process is referred to as metastasis, which represents a major cause of the death from cancer. Indeed, cancer is the second leading cause of death worldwide, with an estimated number of deaths reaching around 9.6 million per year, and according to the World Health Organization represents a huge public health problem.

Ion channels are pore-forming proteins which allows specific ions (e.g., Ca2+, K+, Na+) to cross the membrane thus creating an electrochemical gradient. They can be voltage dependent activated, controlled by neurotransmitter and second messengers or respond to mechanical and thermal stimuli. Some evidence suggests ion channels as key modulators in growth signals, proliferation, apoptosis, angiogenesis, cell differentiation, migration, adhesion, and metastasis in tumor cells. Thus, the role of ion channels as a therapeutical target for an anticancer treatment is innovative and needs additional investigation. 

The purpose of this Issue is to host research and review articles relating to the complex regulatory role of ion channels on pathological processes in different types of cancer.

Dr. Francesco De Logu
Dr. Daniel Souza Monteiro De Araújo
Dr. Romina Nassini
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer
  • tumor
  • ion channel
  • cellular signaling

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

29 pages, 712 KiB  
Review
TRP Channels in Cancer: Signaling Mechanisms and Translational Approaches
by Matilde Marini, Mustafa Titiz, Daniel Souza Monteiro de Araújo, Pierangelo Geppetti, Romina Nassini and Francesco De Logu
Biomolecules 2023, 13(10), 1557; https://doi.org/10.3390/biom13101557 - 22 Oct 2023
Cited by 3 | Viewed by 1943
Abstract
Ion channels play a crucial role in a wide range of biological processes, including cell cycle regulation and cancer progression. In particular, the transient receptor potential (TRP) family of channels has emerged as a promising therapeutic target due to its involvement in several [...] Read more.
Ion channels play a crucial role in a wide range of biological processes, including cell cycle regulation and cancer progression. In particular, the transient receptor potential (TRP) family of channels has emerged as a promising therapeutic target due to its involvement in several stages of cancer development and dissemination. TRP channels are expressed in a large variety of cells and tissues, and by increasing cation intracellular concentration, they monitor mechanical, thermal, and chemical stimuli under physiological and pathological conditions. Some members of the TRP superfamily, namely vanilloid (TRPV), canonical (TRPC), melastatin (TRPM), and ankyrin (TRPA), have been investigated in different types of cancer, including breast, prostate, lung, and colorectal cancer. TRP channels are involved in processes such as cell proliferation, migration, invasion, angiogenesis, and drug resistance, all related to cancer progression. Some TRP channels have been mechanistically associated with the signaling of cancer pain. Understanding the cellular and molecular mechanisms by which TRP channels influence cancer provides new opportunities for the development of targeted therapeutic strategies. Selective inhibitors of TRP channels are under initial scrutiny in experimental animals as potential anti-cancer agents. In-depth knowledge of these channels and their regulatory mechanisms may lead to new therapeutic strategies for cancer treatment, providing new perspectives for the development of effective targeted therapies. Full article
(This article belongs to the Special Issue Ion Channel Signaling in Cancer)
Show Figures

Figure 1

Back to TopTop